DCM
ISEE

Dupont Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Dupont Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,383
Closed -$629K – 1325
2022
Q4 		$629K Buy
+29,383
New +$627K 0.03% 487
2016
Q4 		– Sell
-6,829
Closed -$315K – 879
2016
Q3 		$315K Sell
6,829
-8,606
-56% -$485K 0.01% 626
2016
Q2 		$788K Hold
15,435
– – 0.02% 503
2016
Q1 		$652K Buy
15,435
+6,921
+81% +$353K 0.01% 515
2015
Q4 		$669K Buy
+8,514
New +$492K 0.02% 542

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dupont Capital Management's ISEE Position: Q1 2023 in Review

Dupont Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 29,383 shares — an estimated $629K sold.

Dupont Capital Management first reported a position in ISEE in Q4 2015 and held it in 5 quarters. The position peaked at $788K in Q2 2016. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

  • Dupont Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Dupont Capital Management sold 29,383 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $629K.
  • Dupont Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2015 and held it in 5 quarters.
  • Dupont Capital Management's IVERIC bio, Inc. Common Stock position peaked at $788K in Q2 2016.
  • 223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.